988 related articles for article (PubMed ID: 18000799)
1. Treatment of venous thromboembolism in cancer patients.
Petralia GA; Kakkar AK
Semin Thromb Hemost; 2007 Oct; 33(7):707-11. PubMed ID: 18000799
[TBL] [Abstract][Full Text] [Related]
2. Low molecular weight heparins in cancer. Management and prevention of venous thromboembolism in patients with malignancies.
ten Cate-Hoek AJ; Prins MH
Thromb Res; 2008; 122(5):584-98. PubMed ID: 17996281
[TBL] [Abstract][Full Text] [Related]
3. The treatment of venous thromboembolism in patients with cancer.
Prandoni P
Intern Emerg Med; 2010 Oct; 5 Suppl 1():S27-30. PubMed ID: 20865471
[TBL] [Abstract][Full Text] [Related]
4. Prevention of deep vein thrombosis in cancer patients.
Lee AY
Semin Thromb Hemost; 2007 Oct; 33(7):699-706. PubMed ID: 18000798
[TBL] [Abstract][Full Text] [Related]
5. Long-term use of different doses of low-molecular-weight heparin versus vitamin K antagonists in the treatment of venous thromboembolism.
Romera-Villegas A; Cairols-Castellote MA; Vila-Coll R; Martí-Mestre X; Colomé E; Iguaz I
Ann Vasc Surg; 2010 Jul; 24(5):628-39. PubMed ID: 19932949
[TBL] [Abstract][Full Text] [Related]
6. VTE in patients with cancer--diagnosis, prevention, and treatment.
Lee A
Thromb Res; 2008; 123 Suppl 1():S50-4. PubMed ID: 18824256
[TBL] [Abstract][Full Text] [Related]
7. Role of palliative low-molecular-weight heparin for treating venous thromboembolism in patients with advanced cancer.
Tran QN
Am J Hosp Palliat Care; 2010 Sep; 27(6):416-9. PubMed ID: 20197558
[TBL] [Abstract][Full Text] [Related]
8. Does antithrombotic therapy improve survival in cancer patients?
Cunningham MS; Preston RJ; O'Donnell JS
Blood Rev; 2009 May; 23(3):129-35. PubMed ID: 19046797
[TBL] [Abstract][Full Text] [Related]
9. Antithrombotic therapy and survival in cancer patients.
Kakkar AK
Best Pract Res Clin Haematol; 2009 Mar; 22(1):147-51. PubMed ID: 19285281
[TBL] [Abstract][Full Text] [Related]
10. Cancer-associated venous thrombosis in the surgical setting.
Behranwala KA; Williamson RC
Ann Surg; 2009 Mar; 249(3):366-75. PubMed ID: 19247020
[TBL] [Abstract][Full Text] [Related]
11. Anticoagulation in the treatment of established venous thromboembolism in patients with cancer.
Lee AY
J Clin Oncol; 2009 Oct; 27(29):4895-901. PubMed ID: 19738121
[TBL] [Abstract][Full Text] [Related]
12. Treatment of venous thromboembolism in patients with cancer: subgroup analysis of the Matisse clinical trials.
van Doormaal FF; Raskob GE; Davidson BL; Decousus H; Gallus A; Lensing AW; Piovella F; Prins MH; Büller HR
Thromb Haemost; 2009 Apr; 101(4):762-9. PubMed ID: 19350123
[TBL] [Abstract][Full Text] [Related]
13. The effects of low molecular weight heparins on venous thromboembolism and survival in patients with cancer.
Lee AY
Thromb Res; 2007; 120 Suppl 2():S121-7. PubMed ID: 18023705
[TBL] [Abstract][Full Text] [Related]
14. Development in anticoagulant therapy.
van Doormaal FF; Büller HR; Middeldorp S
Crit Rev Oncol Hematol; 2008 May; 66(2):145-54. PubMed ID: 18032061
[TBL] [Abstract][Full Text] [Related]
15. Venous thromboembolism in patients with advanced cancer under palliative care: additional risk factors, primary/secondary prophylaxis and complications observed under normal clinical practice.
Soto-Cárdenas MJ; Pelayo-García G; Rodríguez-Camacho A; Segura-Fernández E; Mogollo-Galván A; Giron-Gonzalez JA
Palliat Med; 2008 Dec; 22(8):965-8. PubMed ID: 18952751
[TBL] [Abstract][Full Text] [Related]
16. Venous thromboembolism in patients with cancer: an overview for pharmacists using a case-based approach.
Pangilinan JM
J Pharm Pract; 2010 Aug; 23(4):294-302. PubMed ID: 21507829
[TBL] [Abstract][Full Text] [Related]
17. [Treatment of venous thrombosis in cancer patients: practical aspects].
Laza-Achille M; Desruennes E; Di Palma M
Bull Cancer; 2006 Mar; 93(3):271-81. PubMed ID: 16567314
[TBL] [Abstract][Full Text] [Related]
18. Competing events in patients with malignant disease who are at risk for recurrent venous thromboembolism.
Parpia S; Julian JA; Thabane L; Lee AY; Rickles FR; Levine MN
Contemp Clin Trials; 2011 Nov; 32(6):829-33. PubMed ID: 21777700
[TBL] [Abstract][Full Text] [Related]
19. Low-molecular-weight heparin in cancer-associated thrombosis: treatment, secondary prevention, and survival.
Nishioka J; Goodin S
J Oncol Pharm Pract; 2007 Jun; 13(2):85-97. PubMed ID: 17873108
[TBL] [Abstract][Full Text] [Related]
20. A review of the practical advantages of low molecular weight heparin in the treatment of cancer-related venous thromboembolism.
Rhodes S; Bond S
Eur J Oncol Nurs; 2008 Dec; 12(5):425-9. PubMed ID: 18842458
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
